INmune Bio Inc

INMBNASDAQ · USD
2.16USD0.00 (-5.68%)
1310

INmune Bio Inc (INMB) Implied Volatility Current

INMB implied volatility is 89%. IV Rank is 2%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking INMB implied volatility helps you identify when options premiums on INmune Bio Inc are historically cheap or expensive, and where the best trades are hiding. INmune Bio Inc implied volatility reflects the market's expectation of future price movement: when INMB IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor INmune Bio Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For INMB, tracking metrics like INMB IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on INMB signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease.

The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where INMB implied volatility sits today versus where it has been. Our scanner ranks INmune Bio Inc implied volatility against its historical range, surfaces extremes in INMB IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether INmune Bio Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
2.38%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)88.66%

IV Rank2.38%

Historical Volatility (30d)69.67%

IV - HV+18.99%

As of September 22, 2026

Trade options with IV on your side

Track INMB IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial